Simon Haefliger (Simon Häfliger, Simon Hafliger)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Combination Therapy

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Adam J Schoenfeld, Sylvia M Lee, Bernard Doger, Scott N Gettinger, Simon Haefliger, Ammar Sukari, Sophie Papa, Juan Francisco Rodriguez-Moreno, Friedrich Graf Finckenstein, Rana Fiaz, Melissa Catlett, Guang Chen, Rongsu Qi, Emma L Masteller, Viktoria Gontcharova, Kai He
Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non-Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors. Cancer discovery 14 (8) (2024)
Adam J Schoenfeld, Sylvia M Lee, Bernard Doger, Scott N Gettinger, Simon Haefliger, Ammar Sukari, Sophie Papa, Juan Francisco Rodriguez-Moreno, Friedrich Graf Finckenstein, Rana Fiaz, Melissa Catlett, Guang Chen, Rongsu Qi, Emma L Masteller, Viktoria Gontcharova, Kai He
Lifileucel, an Autologous Tumor-infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non-small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors. Cancer discovery (2024)
Adam J Schoenfeld, Sylvia M Lee, Bernard Doger, Scott N Gettinger, Simon Haefliger, Ammar Sukari, Sophie Papa, Juan Francisco Rodriguez-Moreno, Friedrich Graf Finckenstein, Rana Fiaz, Melissa Catlett, Guang Chen, Rongsu Qi, Emma L Masteller, Viktoria Gontcharova, Kai He
Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non-Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors. Cancer discovery 14 (8) (2024)
Adam J Schoenfeld, Sylvia M Lee, Bernard Doger, Scott N Gettinger, Simon Haefliger, Ammar Sukari, Sophie Papa, Juan Francisco Rodriguez-Moreno, Friedrich Graf Finckenstein, Rana Fiaz, Melissa Catlett, Guang Chen, Rongsu Qi, Emma L Masteller, Viktoria Gontcharova, Kai He
Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non-Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors. Cancer discovery 14 (8) (2024)
Adam J Schoenfeld, Sylvia M Lee, Bernard Doger, Scott N Gettinger, Simon Haefliger, Ammar Sukari, Sophie Papa, Juan Francisco Rodriguez-Moreno, Friedrich Graf Finckenstein, Rana Fiaz, Melissa Catlett, Guang Chen, Rongsu Qi, Emma L Masteller, Viktoria Gontcharova, Kai He
Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non-Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors. Cancer discovery 14 (8) (2024)
Adrienne Vancura, Alejandro H Gutierrez, Thorben Hennig, Carlos Pulido Quetglas, Frank J Slack, Rory Johnson, Simon Haefliger
Is Evolutionary Conservation a Useful Predictor for Cancer Long Noncoding RNAs? Insights from the Cancer LncRNA Census 3. Non-coding RNA 8 (6) (2022)
Adrienne Vancura, Alejandro H Gutierrez, Thorben Hennig, Carlos Pulido Quetglas, Frank J Slack, Rory Johnson, Simon Haefliger
Is Evolutionary Conservation a Useful Predictor for Cancer Long Noncoding RNAs? Insights from the Cancer LncRNA Census 3. Non-coding RNA 8 (6) (2022)
Adrienne Vancura, Alejandro H Gutierrez, Thorben Hennig, Carlos Pulido Quetglas, Frank J Slack, Rory Johnson, Simon Haefliger
Is Evolutionary Conservation a Useful Predictor for Cancer Long Noncoding RNAs? Insights from the Cancer LncRNA Census 3. Non-coding RNA 8 (6) (2022)
Adrienne Vancura, Alejandro H Gutierrez, Thorben Hennig, Carlos Pulido Quetglas, Frank J Slack, Rory Johnson, Simon Haefliger
Is Evolutionary Conservation a Useful Predictor for Cancer Long Noncoding RNAs? Insights from the Cancer LncRNA Census 3. Non-coding RNA 8 (6) (2022)
Adrienne Vancura, Alejandro H Gutierrez, Thorben Hennig, Carlos Pulido Quetglas, Frank J Slack, Rory Johnson, Simon Haefliger
Is Evolutionary Conservation a Useful Predictor for Cancer Long Noncoding RNAs? Insights from the Cancer LncRNA Census 3. Non-coding RNA 8 (6) (2022)